Biotech

All Articles

Turnstone lays off 60%, shocks C-suite to stretch out cash money

.Turnstone Biologics is actually minimizing its own headcount through 60% as well as shaking up its ...

Gilead loses hope on $15M MASH bet after reviewing preclinical records

.In a year that has actually observed a permission and a plethora of readouts for metabolic dysfunct...

Texas biotech axes cancer cells contract, pins hopes on excessive weight

.Alaunos Therapeutics is axing an arrangement along with Precigen, losing hope licensing liberties t...

Capricor allotments much more records for DMD treatment after launching BLA

.Capricor Therapeutics is taking a success lap for their period 2 Duchenne muscle dystrophy (DMD) tr...

FDA locations Kezar lupus test in grip observing 4 client deaths

.The FDA has placed Kezar Lifestyle Sciences' lupus trial on hold after the biotech warned 4 fatalit...

Phase 3 Intellectual Stone test reaches SMA target, delivering stock up 200%

.A phase 3 trial of Historian Stone's back muscular degeneration (SMA) prospect has actually hit its...

CAMP 4 is actually most recent to eye IPO, while Upstream define $182M plan

.RNA biotech CAMP4 Rehabs has defined think about a $67 thousand IPO, along with inflammation-focuse...

Galecto acquires leukemia medicine, falls bone cancer cells property in pivot

.A year after the failure of an idiopathic pulmonary fibrosis candidate sent Galecto on a search for...

Judo throws down $100M to knock out renal health condition

.Taking the mat is Judo Biography, a promising biotech armed along with $100 million to establish ol...

AstraZeneca pays out CSPC $100M for preclinical heart disease medicine

.AstraZeneca has paid off CSPC Pharmaceutical Group $100 million for a preclinical heart attack medi...